High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs TCD microemboli
Neurology, ISSN: 0028-3878, Vol: 77, Issue: 8, Page: 744-750
2011
- 128Citations
- 72Usage
- 90Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations128
- Citation Indexes126
- 126
- CrossRef107
- Clinical Citations1
- PubMed Guidelines1
- Policy Citations1
- Policy Citation1
- Usage72
- Abstract Views72
- Captures90
- Readers90
- 81
Article Description
We compared microemboli on transcranial Doppler (TCD) with carotid ulcerations on 3D ultrasound (US) as an additional method for identifying the small proportion of patients with asymptomatic carotid stenosis (ACS) who can benefit from revascularization such as endarterectomy or stenting. Patients with ACS (n = 253) with carotid stenosis >60% by Doppler ultrasound were studied prospectively with TCD embolus detection and 3D US to detect ulcers (the total number of ulcers in both internal carotids) and followed for 3 years. Mean age was 69.66 (SD 8.51) years; 11 (4%) had ≥3 ulcers (Ulcer 3), 11 (6%) had microemboli, and 25 (10%) had microemboli or ≥3 ulcers. Ulcer 3 patients were more likely to have a stroke or death in 3 years (18% vs 2%; p = 0.03), regardless of the side on which the ulcers were found. The 3-year risk of stroke or death was 20% with microemboli vs 2% without ( p = 0.003). The annual rate of ipsilateral stroke was 0.8%. Adding 3D US detection of ulcers doubles (to 10%) the proportion of patients with ACS who may benefit from endarterectomy or stenting. However, until 3-year event rates of stroke or death with endarterectomy or stenting reach <2%, 90% of patients with ACS would be better treated medically until they develop symptoms, ulcers, or emboli. ACE = angiotensin-converting enzyme; ACES = Asymptomatic Carotid Emboli Study; ACS = asymptomatic carotid stenosis; CEA = carotid endarterectomy; SPARC = Stroke Prevention Clinic; TCD = transcranial Doppler; tHcy = total homocysteine; US = ultrasound
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0028387811608650; http://dx.doi.org/10.1212/wnl.0b013e31822b0090; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80054018691&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21849642; https://www.neurology.org/doi/10.1212/WNL.0b013e31822b0090; https://ir.lib.uwo.ca/cnspub/3; https://ir.lib.uwo.ca/cgi/viewcontent.cgi?article=1002&context=cnspub; https://dx.doi.org/10.1212/wnl.0b013e31822b0090; https://n.neurology.org/content/77/8/744; http://www.neurology.org/cgi/doi/10.1212/WNL.0b013e31822b0090; http://www.neurology.org/content/77/8/744.abstract; http://www.neurology.org/content/77/8/744.full; http://www.neurology.org/content/77/8/744.full.pdf; http://www.neurology.org/content/77/8/744; http://www.neurology.org/lookup/doi/10.1212/WNL.0b013e31822b0090; https://www.neurology.org/lookup/doi/10.1212/WNL.0b013e31822b0090; https://n.neurology.org/content/77/8/744.abstract; https://n.neurology.org/content/neurology/77/8/744.full.pdf; http://n.neurology.org/content/77/8/744; http://n.neurology.org/content/77/8/744.abstract; http://n.neurology.org/content/77/8/744.full.pdf
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know